15726 Federal Register / Vol. 74, No. 65 / Tuesday, April 7, 2009 / Notices 

Trans No. Acquiring Acquired Entities 

Transactions Granted Early Termination—02/25/2009 

20090294 ................ General Electric Company ................... ATP Oil & Gas Corporation ................. ATP Infrastructure Partners, L.P. 

Transactions Granted Early Termination—02/27/2009 

20090306 ................ University of Southern California ......... Tenet Healthcare Corporation .............. Tenet HealthSystem Norris, Inc.; USC 

University Hospital, Inc. 

Transactions Granted Early Termination—03/02/2009 

20090143 ................ Intercontinental Exchange, Inc. ............ The Clearing Corporation ..................... The Clearing Corporation 

Transactions Granted Early Termination—03/03/2009 

20090287 ................ Novartis Pharma AG ............................ Portola Pharmaceuticals, Inc. .............. Portola Pharmaceuticals, Inc. 

20090307 ................ Baker Brothers Life Sciences, L.P. ...... Seattle Genetics, Inc. ........................... Seattle Genetics, Inc. 

Transactions Granted Early Termination—03/09/2009 

20090317 ................ DCP Midstream Partners, LP .............. ConocoPhillips ...................................... DCP East Texas Holdings, LLC 

20090318 ................ DCP Midstream Partners, LP .............. Spectra Energy Corp. .......................... DCP East Texas Holdings, LLC 

20090322 ................ Roger Penske ...................................... General Electric Company ................... Penske Truck Leasing Co., L.P. 

Transactions Granted Early Termination—03/11/2009 

20090321 ................ Marsh & McLennan Companies, Inc. .. Callan Associates Inc. .......................... Callan Associates Inc. 

Transactions Granted Early Termination—03/13/2009 

20090263 ................ William Goldring ................................... Constellation Brands, Inc. .................... Barton Brands of California, Inc.; Barton Distillers Import Corp.; Constellation Spirits Inc. 

20090327 ................ Mascolo Brothers Limited .................... Toni & Guy Holdings, Inc. .................... Toni & Guy Holdings, Inc. 

20090333 ................ Fidelity National Financial, Inc. ............ Wind Point Partners V, L.P. ................. VI Acquisition Corp.; VICORP Restaurants, Inc. 

20090336 ................ Newport Global Opportunities Fund 

L.P.

Wind Point Partners V, L.P. ................. VI Acquisition Corp.; VICORP Restaurants, Inc. 

Transactions Granted Early Termination—03/16/2009 

20090311 ................ Fairholme Funds, Inc. .......................... The St. Joe Company .......................... The St. Joe Company. 

20090313 ................ Amphenol Corporation ......................... General Electric Company ................... Times Microwave Systems, Inc. 

FOR FURTHER INFORMATION CONTACT: 

Sandra M. Peay, Contact Representative 

or Renee Hallman, Contact 

Representative, Federal Trade 

Commission, Premerger Notification 

Office, Bureau of Competition, Room H– 

303, Washington, DC 20580, (202) 326– 

3100. 

By Direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. E9–7551 Filed 4–6–09; 8:45 am] 

BILLING CODE 6750–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Guidance on the Genetic Information 

Nondiscrimination Act: Implications 

for Investigators and Institutional 

Review Boards 

AGENCY: Office for Human Research 

Protections, Office of Public Health and 

Science, Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: The Office for Human 

Research Protections (OHRP), Office of 

Public Health and Science, is 

announcing the availability of a 

guidance document entitled, ‘‘Guidance 

on the Genetic Information 

Nondiscrimination Act: Implications for 

Investigators and Institutional Review 

Boards.’’ The guidance document 

provides OHRP’s first formal guidance 

on this topic. The document, which is 

available on the OHRP Web site at 

http://www.hhs.gov/ohrp/ 

humansubjects/guidance/gina.html and 

http://www.hhs.gov/ohrp/ 

humansubjects/guidance/gina.pdf, is 

intended primarily for investigators who 

conduct, and institutional review boards 

(IRB) that review, non-exempt human 

subjects research involving genetic 

testing or collection of genetic 

information (hereinafter referred to as 

‘‘genetic research’’). The guidance 

document provides background on 

protections provided by the Genetic 

Information Nondiscrimination Act of 

2008 (GINA) and discusses some of the 

implications of GINA for investigators 

who conduct, and IRBs that review, 

genetic research, particularly with 

respect to the criteria for IRB approval 

of research and the requirements for 

obtaining informed consent under the 

Department of Health and Human 

Services (HHS) regulations for the 

protection of human subjects (45 CFR 

part 46). 

DATES: Comments on OHRP guidance 

documents are welcome at any time. 

ADDRESSES: Submit written requests for 

single copies of the guidance document 

entitled, ‘‘Guidance on the Genetic 

Information Nondiscrimination Act: 

Implications for Investigators and 

Institutional Review Boards,’’ to the 

Division of Policy and Assurances, 

Office for Human Research Protections, 

1101 Wootton Parkway, Suite 200, 

Rockville, MD 20852. Send one selfaddressed adhesive label to assist that 

Federal Register / Vol. 74, No. 65 / Tuesday, April 7, 2009 / Notices 15727 

office in processing your request, or fax 

your request to 301–402–2071. See the 

SUPPLEMENTARY INFORMATION section for 

information on electronic access to the 

guidance document. Submit written 

comments to GINA GUIDANCE 

COMMENTS, OHRP, 1101 Wootton 

Parkway, Suite 200, Rockville, MD 

20852. Comments also may be sent via 

e-mail to ohrp@hhs.gov or via facsimile 

at 240–453–6909. Comments received, 

including any personal information, 

will be made available to the public 

upon request. 

FOR FURTHER INFORMATION CONTACT: 

Michael A. Carome, M.D., Captain, U.S. 

Public Health Service, OHRP, 1101 

Wootton Parkway, Suite 200, Rockville, 

MD 20852, 240–453–6900; e-mail 

Michael.Carome@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

OHRP, Office of Public Health and 

Science, is announcing the availability 

of a guidance document entitled, 

‘‘Guidance on the Genetic Information 

Nondiscrimination Act: Implications for 

Investigators and Institutional Review 

Boards.’’ The guidance document 

provides OHRP’s first formal guidance 

on this topic. The document applies to 

non-exempt human subjects research 

conducted or supported by HHS and is 

intended primarily for investigators who 

conduct, and IRBs that review, genetic 

research. 

The guidance document provides 

some general background information 

regarding GINA and discusses some of 

the implications of GINA with respect to 

the criteria for IRB approval of research 

and the requirements for obtaining 

informed consent under the HHS 

regulations for the protection of human 

subjects (45 CFR part 46). 

II. Electronic Access 

Persons with access to the Internet 

may obtain the guidance document on 

OHRP’s Web site at http://www.hhs.gov/ 

ohrp/humansubjects/guidance/ 

gina.html and http://www.hhs.gov/ohrp/ 

humansubjects/guidance/gina.pdf. 

III. Request for Comments 

Interested persons may submit 

comments regarding this guidance 

document to OHRP at any time. Please 

see the ADDRESSES section for 

information on where to submit written 

comments. 

Dated: April 1, 2009. 

Jerry Menikoff, 

Director, Office for Human Research 

Protections. 

[FR Doc. E9–7782 Filed 4–6–09; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Cross-Site Evaluation of the 

Infant Adoption Awareness Training 

Program for Projects Initially Funded in 

Fiscal Year 2006. 

OMB No.: New Collection. 

Description: The Administration for 

Children and Families (ACF), Children’s 

Bureau (CB), will conduct the Cross-Site 

Evaluation of the Infant Adoption 

Awareness Training Program (IAATP). 

Title XII, Subtitle A, of the Children’s 

Health Act of 2000 (CHA) authorizes the 

Department of Health and Human 

Services to make Infant Adoption 

Awareness Training grants available to 

national, regional, and local adoption 

organizations for the purposes of 

developing and implementing programs 

that train the staff of public and nonprofit private health service 

organizations to provide adoption 

information and referrals to pregnant 

women on an equal basis with all other 

courses of action included in nondirective counseling of pregnant 

women. Participants in the training 

include individuals who provide 

pregnancy or adoption information and 

those who will provide such services 

after receiving the training, with Title X 

(relating to voluntary family planning 

projects), Section 330 (relating to 

community health centers, migrant 

health centers, and centers serving 

homeless individuals and residents of 

public housing), and CHA-funded 

school-based health centers, receiving 

priority to receive the training. A total 

of six organizations were awarded 

IAATP funding in 2006. 

Section 1201(a)(2)(A) of the IAATP 

legislation requires grantees to develop 

and deliver trainings that are consistent 

with the Best Practice Guidelines for 

Infant Adoption Awareness Training. 

The IAATP guidelines address training 

goals, basic skills, curriculum and 

training structure. A complete 

description of the guidelines is available 

at http://www.acf.hhs.gov/programs/cb/ 

programs_fund/discretionary/iaatp.htm. 

In addition, grantees are required to 

conduct local evaluation of program 

outcomes and participate in the national 

evaluation of the extent to which IAATP 

training objectives are met. The Infant 

Adoption Awareness Training Program: 

Trainee Survey is the primary data 

collection instrument for the national 

cross-site evaluation. Respondents will 

complete the survey prior to receiving 

training and approximately 90 days after 

the training to assess the extent to 

which trainees demonstrate sustained 

gains in their knowledge about 

adoption, and to determine the impact 

of the training on their subsequent work 

with pregnant women. 

1. Do health care workers who 

participate in the IAATP training: 

Demonstrate enhanced knowledge, 

attitudes, skills, and behaviors with 

respect to adoption counseling 

following completion of the program? 

Provide adoption information to 

pregnant women on an equal basis with 

other pregnancy planning options? 

Demonstrate enhanced awareness of 

community adoption-related resources 

and refer expectant mothers to them as 

needed? 

2. Are trainees more confident about 

discussing all three pregnancy planning 

options (parenting, abortion, and 

adoption) in a non-directive counseling 

style than they were prior to 

participating in the training? Cross-site 

evaluation data will be collected on an 

annual basis throughout the five-year 

funding period. Pre-test and follow-up 

versions of the survey are expected to 

require approximately 10 to 15 minutes 

to complete. Estimated response time 

for the follow-up survey includes time 

for respondents to access the Web-based 

survey, complete the survey online, and 

electronically submit the survey. 

Respondents will not need to 

implement a recordkeeping system or 

compile source data in order to 

complete the survey. Where possible, 

fields in the follow-up version of the 

survey will be pre-filled with static data 

from the respondents pre-test (e.g., 

demographics, agency type) in order to 

further expedite completion of the 

survey and minimize respondent 

burden. 

Respondents: Infant Adoption 

Awareness Program Trainees.